AIH |
Autoimmune hepatitis |
ALH |
Acute liver failure |
ANA |
Anti-nuclear antibodies |
APAP |
(N-) Acetyl-para-aminophenol, acetaminophen |
APC |
Antigen-presenting cells |
CARD10 |
Caspase recruitment domain 10 |
Cbl-bCTLA-4 |
Casitas B-cell lymphomaCytotoxic T lymphocyte antigen 4 |
CYP |
Cytochrome P450 |
DAMPs |
Damage associated molecular pattern molecules |
DILI |
Drug-induced liver injury |
DC |
Dendritic cells |
DRESS |
Drug rash with eosinophilia and systemic symptoms |
ELISAFTCD |
Enzyme-linked Immunosorbent AssayFormiminotransferase cyclodeaminase |
FXR |
Farnesoid X receptor |
GWAS |
Genome-wide association study |
GST |
Glutathione S-transferase |
HDS |
Herbal and dietary supplements |
HLA |
Human leucocyte antigen |
IAIHG |
International autoimmune hepatitis group |
IL |
Interleukin |
IFNγ |
Interferon gamma |
LC1 |
Liver cytosol 1 |
LKM |
Liver-kidney microsomes |
LSEC |
Liver sinusoidal endothelial cells |
MELD |
Model of end-stage liver disease |
MDR3 |
Multidrug resistance protein 3 |
MHC |
Major histocompatibility complex |
MS |
Multiple sclerosis |
NAC |
N-acetylcysteine |
NAPQI |
N-acetyl-p-benzoquinoneimine |
NAT2 |
N-acetyltransferase 2 |
PBMC |
Peripheral blood mononuclear cells |
PD-1 |
Programmed cell death-1 |
RNA |
Ribonucleic acid |
ROS |
Reactive oxygen species |
RUCAM |
Roussel uclaf causality assessment method |
SEPSECS |
O-phosphoseryl-tRNA:selenocysteinyl-tRNA synthase |
SH2B3 |
Scr homology 2 adaptor protein 3 |
SLA/LP |
Soluble liver antigen/Liver-pancreas antigen |
SMA |
Smooth muscle antigen |
TGFβ |
Transforming growth factor beta |
TNFα |
Tumor necrosis factor-alpha |
Treg |
Regulatory T cells |